Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

What is the purpose of this trial?

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.


Participation Guidelines

Ages: 18 - 70 years

Gender: Both


University of Louisville

Dates: 06/01/2017 - 02/01/2018

Last Updated: 07/09/2017

Study HIC#: 1601017127

Get Involved

For more information about this study, contact:
Louise M McLellan
203-737-7166
louise.mclellan@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image